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journal homepage: www.e lsev ier .com/ locate / j j ccechocardiography or transthoracic echocardiography?The important point of transcatheter atrial septal defect (ASD)
closure is the decision of indication and monitoring of device
position during procedure. Transesophageal echocardiography
(TEE) monitoring of transcatheter ASD closure began from the
clamshell occluder procedure [1]. The early period of transcatheter
ASD closure by clamshell occluder was done only by ﬂuoroscopy
monitoring. Device migration after implantation was experienced
and lack of ASD rimswas observed during surgical ﬁndings in those
cases. Evaluation of detailed ASD anatomy by TEE and TEE
monitoring began after those experiences. Success rates of the
procedure were improved after this decision. TEE became the gold
standard of transcatheter ASD closure monitoring after this
episode. TEE was also used for another type of ASD occlusion
devices for monitoring.
Transcatheter ASD closure by AmplatzerTM Septal Occluder
(St. JudeMedical, St. Paul, MN, USA) began from 2007 in Japan. This
was the latest start of this procedure in theworld. The evaluation of
ASD anatomy andmonitoring of procedure are very important. The
most important part of ASD anatomical evaluation is accurate size
of ASD and rims around ASD. Rim deﬁciency and hypoplastic rim
are caused by device migration and erosion [2]. TEE or intracardiac
echocardiography (ICE) is the main monitoring tool in the USA and
Europe. The Society of Japan Pediatric Interventional Cardiology
(JPIC) decided that TEE and ICE are the monitoring tools of
procedures and transthoracic echocardiography (TTE) monitoring
is not permitted [3]. However, TTEmonitoring of transcatheter ASD
closure is undertaken widely in Asian countries, because with TTE
monitoring it is possible to perform ASD closure without general
anesthesia. Small ASD closure is possible with TTE monitoring in
my opinion. But, with TEE it is difﬁcult to evaluate hypoplastic
inferior rim and posterior rim, and superior rim defect. Only TTE
monitoring of transcatheter ASD closures for hypoplastic rim cases
or borderline cases increases the risk of erosion and device
migration. But a limited number of institutions can do transcath-
eter ASD closure in China and one institute has much experience.
They can detect high-risk cases from their rich experience [4]. But
the number of institutions performing transcatheter ASD closure in
Japan is large and the average number of procedures per institution
is only 10 cases per year. Most new institutions have limited
experience. In addition, a recent recommendation suggests that
evaluation of aortic rim is important to prevent erosion [5]. InDOI of original article: http://dx.doi.org/10.1016/j.jjcc.2014.03.014.
http://dx.doi.org/10.1016/j.jjcc.2014.06.002
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. Open acceparticular, a wide area of aortic rim defect is at high risk of erosion.
However, defective or hypoplastic aortic rim is common in ASD.
Evaluation of rim defect area is not easy and Mallula and Amin [5]
recommended TEE or ICE evaluation and not TTE. TEE or ICE
evaluations are costly and time-consuming, but are safe and
accurate. However, the value of information from TEE or ICE differs
between experienced and inexperienced institutions. Careful and
thoughtful observation and procedures are required.
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